Clay B. Siegall
2016
In 2016, Clay B. Siegall earned a total compensation of $9.6M as President and CEO at Seattle Genetics, a 39% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $985,000 |
|---|---|
| Option Awards | $4,015,160 |
| Salary | $852,354 |
| Stock Awards | $3,686,600 |
| Other | $20,283 |
| Total | $9,559,397 |
Siegall received $4M in option awards, accounting for 42% of the total pay in 2016.
Siegall also received $985K in non-equity incentive plan, $852.4K in salary, $3.7M in stock awards and $20.3K in other compensation.
Rankings
In 2016, Clay B. Siegall's compensation ranked 558th out of 14,075 executives tracked by ExecPay. In other words, Siegall earned more than 96.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 558 out of 14,075 | 96th |
Division Manufacturing | 178 out of 5,488 | 97th |
Major group Chemicals And Allied Products | 42 out of 1,900 | 98th |
Industry group Drugs | 27 out of 1,543 | 98th |
Industry Biological Products, Except Diagnostic Substances | 8 out of 287 | 97th |
Source: SEC filing on April 5, 2017.
Siegall's colleagues
We found six more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2016.
2016
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2016
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2016
Vaughn Himes
Seattle Genetics
Chief Technical Officer
2016
Darren Cline
Seattle Genetics
Former Executive Vice President, Commercial
2016
Todd Simpson
Seattle Genetics
Chief Financial Officer
2016
Jean Liu
Seattle Genetics